Journal Article Review Research Support, N.I.H., Extramural Ppublish 6 citations
PubMed: 38269585 DOI: 10.1161/ATVBAHA.123.320045
Prostanoids in Cardiac and Vascular Remodeling.
Arterioscler Thromb Vasc Biol 44(3):558-583
Authors: Emanuela Ricciotti, Philip G Haines, William Chai, Garret A FitzGerald
Affiliations
- Department of Systems Pharmacology and Translational Therapeutics (E.R. G.A.F.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Institute for Translational Medicine and Therapeutics (E.R. G.A.F.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
- Rhode Island Hospital, Department of Medicine, Warren Alpert Medical School of Brown University, Providence (P.G.H.).
- Health and Human Biology, Division of Biology and Medicine, Brown University, Providence, RI (W.C.).
- Department of Medicine (G.A.F.), University of Pennsylvania Perelman School of Medicine, Philadelphia.
Abstract
Prostanoids are biologically active lipids generated from arachidonic acid by the action of the COX (cyclooxygenase) isozymes. NSAIDs, which reduce the biosynthesis of prostanoids by inhibiting COX activity, are effective anti-inflammatory, antipyretic, and analgesic drugs. However, their use is limited by cardiovascular adverse effects, including myocardial infarction, stroke, hypertension, and heart failure. While it is well established that NSAIDs increase the risk of atherothrombotic events and hypertension by suppressing vasoprotective prostanoids, less is known about the link between NSAIDs and heart failure risk. Current evidence indicates that NSAIDs may increase the risk for heart failure by promoting adverse myocardial and vascular remodeling. Indeed, prostanoids play an important role in modulating structural and functional changes occurring in the myocardium and in the vasculature in response to physiological and pathological stimuli. This review will summarize current knowledge of the role of the different prostanoids in myocardial and vascular remodeling and explore how maladaptive remodeling can be counteracted by targeting specific prostanoids.
MeSH
Hypertension, Myocardial Infarction, Heart Failure, Heart, Prostaglandins, Arteriosclerosis, Vascular Diseases, Vascular Remodeling, Analgesics, Thrombosis
Cited by
- Molecular Thumbprints: Biological Signatures That Measure Loss of Identity. Biomolecules, 2024
- Prostaglandins and the Cardiovascular System. Arterioscler Thromb Vasc Biol, 2025
- Transcriptomic Analysis of Arachidonic Acid Pathway Genes Provides Mechanistic Insight into Multi-Organ Inflammatory and Vascular Diseases. Genes (Basel), 2024
- Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment. Pulm Circ, 2025